Interphex 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Interphex 2010

Presents April 20 - 21, 2010
The Main Stage at INTERPHEX
Front of Hall A

Lights, Camera, Action! Stop by the Main Stage at INTERPHEX and get a front row seat to compelling interviews, exciting new product announcements and industry innovations. Join the editors of Pharmaceutical Technology and BioPharm International for a series of in-depth conversations with INTERPHEX Conference speakers, FDA representatives, industry stakeholders and thought leaders. In between live interviews, view announcements of new products and enhancements from exhibitors and winners of the 2010 Facility of the Year Awards.

Join Your Colleagues at INTERPHEX for the Signature Series



April 21, 2010
NEW! Signature Series
Open to all badge holders
Introducing The Signature Series at INTERPHEX ? a compelling selection of presentations on critical subjects affecting the pharmaceutical industry. Join your colleagues for continental breakfast and then attend the Signature Series presentation of greatest interest and application to you.

8:30AM - Continental Breakfast
9:00 AM - 10:00 AM | Room: 1E14
Deficiencies in New Drug Applications
Aloka Srinivasan, Office of Generic Drugs, CDER, FDA; Robert Iser, Office of Generic Drugs, CDER, FDA & Richard Lostritto, Director of Division-III, Office of New Drug Quality Assessment (ONDQA), FDA

Join these speakers from 10.30- 11.30 am on the Main Stage to take questions from conference attendees or submit your questions on deficiencies in advance
Aloka Srinivasan
Aloka Srinivasan
Robert Iser
Robert Iser
Richard Lostritto
Richard Lostritto

9:00 AM - 10:00 AM | Room: 1E16
Supply-Chain Security: What to Expect in the Next Decade
Guy Villax, Chief Executive Officer, Hovione


9:00 AM - 10:00 AM | Room: 1E15
The State of the Outsourcing Industry
Jim Miller, President, PharmSource
Jim Miller


Main Stage Events from PharmTech and BioPharm International
Click here to download a schedule

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here